Stoke Therapeutics’ (STOK) Buy Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note published on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $22.00 target price on the stock. STOK has been the subject of a number of other reports. Leerink Partnrs raised Stoke […]
More Stories
ASML Holding (NASDAQ:ASML) Shares Bought by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS grew its position in ASML Holding (NASDAQ:ASML – Free Report) by 35.3% during the third...
Investec Group (LON:INVP) Hits New 12-Month High – Here’s Why
Shares of Investec Group (LON:INVP – Get Free Report) reached a new 52-week high during mid-day trading on Thursday ....
Vanguard Total World Stock ETF (NYSEARCA:VT) Reaches New 1-Year High – Still a Buy?
Vanguard Total World Stock ETF (NYSEARCA:VT – Get Free Report) shares hit a new 52-week high on Thursday . The...
Traders Purchase High Volume of iShares Russell 2000 Value ETF Call Options (NYSEARCA:IWN)
iShares Russell 2000 Value ETF (NYSEARCA:IWN – Get Free Report) was the target of unusually large options trading activity on...
Acushnet (NYSE:GOLF) Reaches New 12-Month High – Should You Buy?
Shares of Acushnet Holdings Corp. (NYSE:GOLF – Get Free Report) reached a new 52-week high during trading on Thursday ....
OppFi (NYSE:OPFI) Hits New 12-Month High – Here’s What Happened
Shares of OppFi Inc. (NYSE:OPFI – Get Free Report) hit a new 52-week high on Thursday . The stock traded...